NCT03108937View on ClinicalTrials.gov

Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

September 8, 2017

Conditions
Breast Cancer
Interventions
DRUG

Dexmedetomidine

Patients in the experimental group will receive Dexmedetomidine during surgery.

DRUG

saline

Patients in the control group will receive saline but not Dexmedetomidine during surgery.

Trial Locations (1)

200127

Renji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT03108937 - Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro | Biotech Hunter | Biotech Hunter